The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing, registrational-intent, phase IIb trial in ...

The 32-year-old teacher had two pregnancies since she found out she had inherited a gene that contributed to her colorectal cancer, which was diagnosed in August 2020. Her first pregnancy occurred ...

Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...

Every cell in the body normally has its fixed place as part of a tissue structure. Except for a few cell types, such as blood ...

The University of Barcelona has participated in an international study that has found new evidence linking traumatic experiences and stressful events with endometriosis, a chronic systemic ...

Professor Kwang-Hyun Cho's research team of the Department of Bio and Brain Engineering at KAIST has captured the critical ...

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.